Natixis Advisors, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Natixis Advisors, L.P.

  • $68.5 Billion
  • Q3 2025

A detailed history of Natixis Advisors, L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 120,109 shares of REGN stock, worth $83.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
120,109
Previous 113,025 6.27%
Holding current value
$83.3 Million
Previous $59.3 Million 13.81%
% of portfolio
0.1%
Previous 0.09%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$534.91 - $598.71 $3.79 Million - $4.24 Million
7,084 Added 6.27%
120,109 $67.5 Million
Q2 2025

Aug 13, 2025
SELL
$483.07 - $625.6 $1.55 Million - $2.01 Million
-3,207 Reduced 2.76%
113,025 $59.3 Million
Q1 2025

May 08, 2025
BUY
$634.14 - $744.83 $3.99 Million - $4.69 Million
6,294 Added 5.73%
116,232 $73.7 Million
Q4 2024

Feb 10, 2025
SELL
$701.85 - $1046.91 $4.96 Million - $7.4 Million
-7,064 Reduced 6.04%
109,938 $78.3 Million
Q3 2024

Nov 06, 2024
BUY
$1024.09 - $1201.76 $326,684 - $383,361
319 Added 0.27%
117,002 $123 Million
Q2 2024

Aug 01, 2024
BUY
$883.2 - $1071.19 $2.4 Million - $2.91 Million
2,720 Added 2.39%
116,683 $123 Million
Q1 2024

Apr 25, 2024
BUY
$902.69 - $993.35 $3.2 Million - $3.52 Million
3,546 Added 3.21%
113,963 $110 Million
Q4 2023

Feb 06, 2024
SELL
$775.18 - $881.7 $468,208 - $532,546
-604 Reduced 0.54%
110,417 $97 Million
Q3 2023

Nov 13, 2023
SELL
$692.45 - $844.37 $85,171 - $103,857
-123 Reduced 0.11%
111,021 $91.4 Million
Q2 2023

Aug 15, 2023
SELL
$700.03 - $830.35 $601,325 - $713,270
-859 Reduced 0.77%
111,144 $79.9 Million
Q1 2023

May 11, 2023
BUY
$680.49 - $826.97 $3.12 Million - $3.79 Million
4,588 Added 4.27%
112,003 $92 Million
Q4 2022

Jan 27, 2023
SELL
$705.89 - $766.39 $19.4 Million - $21 Million
-27,451 Reduced 20.35%
107,415 $77.5 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $187,114 - $236,128
-326 Reduced 0.24%
134,866 $92.9 Million
Q2 2022

Aug 12, 2022
SELL
$548.35 - $738.84 $22.3 Million - $30.1 Million
-40,701 Reduced 23.14%
135,192 $79.9 Million
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $3.21 Million - $3.77 Million
-5,398 Reduced 2.98%
175,893 $123 Million
Q4 2021

Feb 08, 2022
SELL
$543.48 - $670.97 $38.9 Million - $48 Million
-71,561 Reduced 28.3%
181,291 $114 Million
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $66.4 Million - $78.8 Million
115,720 Added 84.39%
252,852 $153 Million
Q2 2021

Aug 12, 2021
SELL
$472.8 - $558.54 $570,196 - $673,599
-1,206 Reduced 0.87%
137,132 $76.6 Million
Q1 2021

May 05, 2021
SELL
$446.73 - $548.2 $2.27 Million - $2.78 Million
-5,075 Reduced 3.54%
138,338 $65.5 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $20.6 Million - $26.2 Million
-43,123 Reduced 23.12%
143,413 $69.3 Million
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $4.34 Million - $5.25 Million
-7,972 Reduced 4.1%
186,536 $104 Million
Q2 2020

Aug 11, 2020
SELL
$493.32 - $643.92 $7.29 Million - $9.52 Million
-14,786 Reduced 7.06%
194,508 $121 Million
Q1 2020

Apr 27, 2020
BUY
$336.18 - $494.43 $209,776 - $308,524
624 Added 0.3%
209,294 $102 Million
Q4 2019

Feb 10, 2020
SELL
$274.13 - $376.51 $472,051 - $648,350
-1,722 Reduced 0.82%
208,670 $78.4 Million
Q3 2019

Nov 12, 2019
BUY
$273.46 - $318.39 $963,399 - $1.12 Million
3,523 Added 1.7%
210,392 $58.4 Million
Q2 2019

Aug 12, 2019
BUY
$299.6 - $414.82 $141,111 - $195,380
471 Added 0.23%
206,869 $64.8 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $2.72 Million - $3.21 Million
7,309 Added 3.67%
206,398 $84.8 Million
Q4 2018

Feb 13, 2019
SELL
$335.82 - $403.04 $2.4 Million - $2.89 Million
-7,161 Reduced 3.47%
199,089 $74.4 Million
Q3 2018

Nov 13, 2018
BUY
$351.14 - $408.51 $5.91 Million - $6.87 Million
16,826 Added 8.88%
206,250 $83.3 Million
Q2 2018

Aug 14, 2018
BUY
$284.6 - $344.99 $3.03 Million - $3.67 Million
10,649 Added 5.96%
189,424 $0
Q1 2018

May 10, 2018
BUY
$315.82 - $393.78 $14.7 Million - $18.4 Million
46,611 Added 35.27%
178,775 $61.6 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $1.48 Million - $1.94 Million
4,130 Added 3.23%
132,164 $49.7 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $55.2 Million - $64.5 Million
128,034
128,034 $57.2 Million

Others Institutions Holding REGN

# of Institutions
1,463
Shares Held
86.4M
Call Options Held
2.42M
Put Options Held
1.64M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email